Prediction of matrix metal proteinases-12 inhibitors by machine learning approaches

References

• Amar, S., & Fields, G. B. (2015). Potential clinical implications of recent matrix metalloproteinase inhibitor design strategies. Expert Review of Proteomics, 12(5), 445–447. doi: 10.1586/14789450.2015.1069190
   PubMed Web of Science ®Google Scholar
• Ando, N., & Terashima, S. (2007). Synthesis and matrix metalloproteinase (MMP)-12 inhibitory activity of ageladine A and its analogs. Bioorganic & Medicinal Chemistry Letters, 17(16), 4495–4499. doi: https://doi.org/10.1016/j.bmcl.2007.06.005
   PubMed Web of Science ®Google Scholar
• Ando, N., & Terashima, S. (2009). Synthesis of novel ageladine A analogs showing more potent matrix metalloproteinase (MMP)-12 inhibitory activity than the natural product. Bioorganic & Medicinal Chemistry Letters, 19(18), 5461–5463. doi: https://doi.org/10.1016/j.bmcl.2009.07.099
   PubMed Web of Science ®Google Scholar
• Balaz, P., Friess, H., Kondo, Y., Zhu, Z., Zimmermann, A., & Büchler, M. W. (2002). Human macrophage metalloelastase worsens the prognosis of pancreatic cancer. Annals of Surgery, 235(4), 519–527
   PubMed Web of Science ®Google Scholar
• Breiman, L. (2001). Random forests. Machine Learning, 45(1), 5–32. doi: 10.1023/a:1010933404324
   Web of Science ®Google Scholar
• Burkert., U., & Allinger, N. L. (1982). ACS monograph: Molecular mechanics. Washington, DC: American Chemical Society.
   Google Scholar
• Cartier, A., & Rivail, J. L. (1987). Electronic descriptors in quantitative structure—Activity relationships. Chemometrics and Intelligent Laboratory Systems, 1(4), 335–347. doi: https://doi.org/10.1016/0169-7439(87)80039-4
   Web of Science ®Google Scholar
• Chelluboina, B., Klopfenstein, J. D., Pinson, D. M., Wang, D. Z., Vemuganti, R., & Veeravalli, K. K. (2015). Matrix metalloproteinase-12 induces blood–brain barrier damage after focal cerebral ischemia. Stroke, 46(12), 3523–3531. doi: 10.1161/strokeaha.115.011031
   PubMed Web of Science ®Google Scholar
• Chelluboina, B., Nalamolu, K. R., Klopfenstein, J. D., Pinson, D. M., Wang, D. Z., Vemuganti, R., & Veeravalli, K. K. (2018). MMP-12, a promising therapeutic target for neurological diseases. Molecular Neurobiology, 55(2), 1405–1409. doi: 10.1007/s12035-017-0418-5
   PubMed Web of Science ®Google Scholar
• Chiba, Y., Yu, Y., Sakai, H., & Misawa, M. (2007). Increase in the expression of matrix metalloproteinase-12 in the airways of rats with allergic bronchial asthma. Biological & Pharmaceutical Bulletin, 30(2), 318–323
   PubMed Web of Science ®Google Scholar
• Cong, Y., Yang, X.-g., Lv, W., & Xue, Y. (2009). Prediction of novel and selective TNF-alpha converting enzyme (TACE) inhibitors and characterization of correlative molecular descriptors by machine learning approaches. Journal of Molecular Graphics and Modelling, 28(3), 236–244. doi: https://doi.org/10.1016/j.jmgm.2009.08.001
   PubMed Web of Science ®Google Scholar
• Corina (Version 3.4). (2006). Germany: Molecular Networks GmbH-Computerchemie.
   Google Scholar
• Curci, J. A., Liao, S., Huffman, M. D., Shapiro, S. D., & Thompson, R. W. (1998). Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. The Journal of Clinical Investigation, 102(11), 1900–1910. doi: 10.1172/JCI2182
   PubMed Web of Science ®Google Scholar
• Devel, L., Czarny, B., Beau, F., Georgiadis, D., Stura, E., & Dive, V. (2010). Third generation of matrix metalloprotease inhibitors: Gain in selectivity by targeting the depth of the S1′ cavity. Biochimie, 92(11), 1501–1508. doi: https://doi.org/10.1016/j.biochi.2010.07.017
   PubMed Web of Science ®Google Scholar
• Devel, L., Garcia, S., Czarny, B., Beau, F., Lajeunesse, E., Vera, L., …, Dive, V. (2010). Insights from selective non-phosphinic inhibitors of MMP-12 tailored to fit with an S1′ loop canonical conformation. Journal of Biological Chemistry, 285(46), 35900–35909. doi: 10.1074/jbc.M110.139634
   PubMed Web of Science ®Google Scholar
• Devel, L., Rogakos, V., David, A., Makaritis, A., Beau, F., Cuniasse, P., …, Dive, V. (2006). Development of selective inhibitors and substrate of matrix metalloproteinase-12. Journal of Biological Chemistry, 281(16), 11152–11160. doi: 10.1074/jbc.M600222200
   PubMed Web of Science ®Google Scholar
• Dhanabal, S., & Chandramathi, S. (2011). A review of various k-nearest neighbor query processing techniques. International Journal of Computer Applications, 31(7), 14–22
   Google Scholar
• Ding, Y., Shimada, Y., Gorrin-Rivas, M. J., Itami, A., Li, Z., Hong, T., … Imamura, M. (2002). Clinicopathological significance of human macrophage metalloelastase expression in esophageal squamous cell carcinoma. Oncology, 63(4), 378–384
   PubMed Web of Science ®Google Scholar
• Discovery Studio Modeling Environment (Version 3.5). (2005). San Diego, CA, USA: Accelrys Software Inc.
   Google Scholar
• Dublanchet, A.-C., Ducrot, P., Andrianjara, C., O’Gara, M., Morales, R., Compère, D., … Tertre, A. (2005). Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors. Bioorganic & Medicinal Chemistry Letters, 15(16), 3787–3790. doi: https://doi.org/10.1016/j.bmcl.2005.05.079
   PubMed Web of Science ®Google Scholar
• Fabre, B., Ramos, A., & de Pascual-Teresa, B. (2014). Targeting matrix metalloproteinases: exploring the dynamics of the S1′ pocket in the design of selective, small molecule inhibitors. Journal of Medicinal Chemistry, 57(24), 10205–10219. doi: 10.1021/jm500505f
   PubMed Web of Science ®Google Scholar
• Fawcett, T. (2006). An introduction to ROC analysis. Pattern Recognition Letters, 27(8), 861–874. doi: https://doi.org/10.1016/j.patrec.2005.10.010
   Web of Science ®Google Scholar
• Gunda, S. K., Akula, L. K., Shaik, S., Bandi, S., & Shaik, M. (2015). Molecular docking and 3D-QSAR analysis studies of MMP-12 inhibitors. International Journal of Pharmaceutical Sciences and Research, 6(5), 2019–2027.
   Web of Science ®Google Scholar
• Gupta, S. P., & Patil, V. M. (2012). Specificity of binding with matrix metalloproteinases. In S. P. Gupta (Ed.), Matrix metalloproteinase inhibitors: Specificity of binding and structure activity relationships (pp. 35–56). Basel: Springer Basel.
   Google Scholar
• Hadizadeh, F., & Shamsara, J. (2015). Receptor-based 3D-QSAR approach to find selectivity features of flexible similar binding sites: case study on MMP-12/MMP-13. International Journal of Bioinformatics Research and Applications, 11(4), 326–346. doi: 10.1504/ijbra.2015.070139
   PubMedGoogle Scholar
• Hall, L. H., & Kier, L. B. (1995). Electrotopological state indices for atom types: A novel combination of electronic, topological, and valence state information. Journal of Chemical Information and Computer Sciences, 35(6), 1039–1045
   Google Scholar
• Hall, L. H., & Kier, L. B. (2007). The molecular connectivity chi indexes and kappa shape indexes in structure-property modeling. In K. B. Lipkowitz & D. B. Boyd (Eds.), Reviews in computational Chemistry (II ed., pp. 367–422). New York: Wiley.
   Google Scholar
• Hautamaki, R. D., Kobayashi, D. K., Senior, R. M., & Shapiro, S. D. (1997). Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science, 277(5334), 2002–2004. doi: 10.1126/science.277.5334.2002
   PubMed Web of Science ®Google Scholar
• Hitaoka, S., Chuman, H., & Yoshizawa, K. (2015). A QSAR study on the inhibition mechanism of matrix metalloproteinase-12 by arylsulfone analogs based on molecular orbital calculations. Organic & Biomolecular Chemistry, 13(3), 793–806. doi: 10.1039/C4OB01843E
   PubMed Web of Science ®Google Scholar
• Hofmann, H.-S., Hansen, G., Richter, G., Taege, C., Simm, A., Silber, R.-E., & Burdach, S. (2005). Matrix metalloproteinase-12 expression correlates with local recurrence and metastatic disease in non–small cell lung cancer patients. Clinical Cancer Research, 11(3), 1086–1092.
   PubMed Web of Science ®Google Scholar
• Holmes, I. P., Gaines, S., Watson, S. P., Lorthioir, O., Walker, A., Baddeley, S. J., … Martin, S. L. (2009). The identification of β-hydroxy carboxylic acids as selective MMP-12 inhibitors. Bioorganic & Medicinal Chemistry Letters, 19(19), 5760–5763. doi: https://doi.org/10.1016/j.bmcl.2009.07.155
   PubMed Web of Science ®Google Scholar
• Jain, A. K. (2010). Data clustering: 50 years beyond K-means. Pattern Recognition Letters, 31(8), 651–666. doi: https://doi.org/10.1016/j.patrec.2009.09.011
   Web of Science ®Google Scholar
• Jiang, M.-N., Zhou, X.-P., Sun, D.-R., Gao, H., Zheng, Q.-C., Zhang, H.-X., & Liang, D. (2017). 2D-QSAR study, molecular docking, and molecular dynamics simulation studies of interaction mechanism between inhibitors and transforming growth factor-beta receptor I (ALK5). Journal of Biomolecular Structure and Dynamics, 1–13. doi: 10.1080/07391102.2017.1396256
   PubMedGoogle Scholar
• Johnson, J. L., Devel, L., Czarny, B., George, S. J., Jackson, C. L., Rogakos, V., … Dive, V. (2011). A selective matrix metalloproteinase-12 inhibitor retards atherosclerotic plaque development in apolipoprotein E–knockout mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 31(3), 528–535. doi: 10.1161/atvbaha.110.219147
   PubMed Web of Science ®Google Scholar
• Johnson, J. L., George, S. J., Newby, A. C., & Jackson, C. L. (2005). Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries. Proceedings of the National Academy of Sciences, 102(43), 15575–15580. doi: 10.1073/pnas.0506201102
   PubMed Web of Science ®Google Scholar
• Johnson, M., & Maggiora, G. (Eds.). (1990). Concepts and applications of molecular similarity. New York: Wiley.
   Google Scholar
• Kamath, V., & Pai, A. (2017). Application of molecular descriptors in modern computational drug design–An overview. Research Journal of Pharmacy and Technology, 10(9), 3237–3241.
   Google Scholar
• Kaneko, Y., Sakatsume, M., Xie, Y., Kuroda, T., Igashima, M., Narita, I., & Gejyo, F. (2003). Macrophage metalloelastase as a major factor for glomerular injury in anti-glomerular basement membrane nephritis. The Journal of Immunology, 170(6), 3377–3385. doi: 10.4049/jimmunol.170.6.3377
   PubMed Web of Science ®Google Scholar
• Karelson, M., Lobanov, V. S., & Katritzky, A. R. (1996). Quantum-chemical descriptors in QSAR/QSPR studies. Chemical Reviews, 96(3), 1027–1044. doi: 10.1021/cr950202r
   PubMed Web of Science ®Google Scholar
• Kerkelä, E., Ala-aho, R., Jeskanen, L., Rechardt, O., Grénman, R., Shapiro, S. D., … Saarialho-Kere, U. (2000). Expression of human macrophage metalloelastase (mmp-12) by tumor cells in skin cancer. Journal of Investigative Dermatology, 114(6), 1113–1119. doi: https://doi.org/10.1046/j.1523-1747.2000.00993.x
   PubMed Web of Science ®Google Scholar
• Lagente, V., Le Quement, C., & Boichot, E. (2009). Macrophage metalloelastase (MMP-12) as a target for inflammatory respiratory diseases. Expert Opinion on Therapeutic Targets, 13(3), 287–295. doi: 10.1517/14728220902751632
   PubMed Web of Science ®Google Scholar
• Lavecchia, A. (2015). Machine-learning approaches in drug discovery: Methods and applications. Drug Discovery Today, 20(3), 318–331. doi: https://doi.org/10.1016/j.drudis.2014.10.012
   PubMed Web of Science ®Google Scholar
• Lei, T., Sun, H., Kang, Y., Zhu, F., Liu, H., Zhou, W., … Hou, T. (2017). ADMET evaluation in drug discovery. 18. Reliable prediction of chemical-induced urinary tract toxicity by boosting machine learning approaches. Molecular Pharmaceutics, 14(11), 3935–3953. doi: 10.1021/acs.molpharmaceut.7b00631
   PubMed Web of Science ®Google Scholar
• Li, B.-K., Cong, Y., Yang, X.-G., Xue, Y., & Chen, Y.-Z. (2013). In silico prediction of spleen tyrosine kinase inhibitors using machine learning approaches and an optimized molecular descriptor subset generated by recursive feature elimination method. Computers in Biology and Medicine, 43(4), 395–404. doi: https://doi.org/10.1016/j.compbiomed.2013.01.015
   PubMed Web of Science ®Google Scholar
• Li, B.-K., He, B., Tian, Z.-Y., Chen, Y.-Z., & Xue, Y. (2015). Modeling, predicting and virtual screening of selective inhibitors of MMP-3 and MMP-9 over MMP-1 using random forest classification. Chemometrics and Intelligent Laboratory Systems, 147, 30–40. doi: https://doi.org/10.1016/j.chemolab.2015.07.014
   Web of Science ®Google Scholar
• Li, W., Li, J., Wu, Y., Rancati, F., Vallese, S., Raveglia, L., … Mansour, T. S. (2009). Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma. Journal of Medicinal Chemistry, 52(17), 5408–5419. doi: 10.1021/jm900809r
   PubMed Web of Science ®Google Scholar
• Li, W., Li, J., Wu, Y., Wu, J., Hotchandani, R., Cunningham, K., … Mansour, T. S. (2009). A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): Discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408). Journal of Medicinal Chemistry, 52(7), 1799–1802. doi: 10.1021/jm900093d
   PubMed Web of Science ®Google Scholar
• Liang, J., Liu, E., Yu, Y., Kitajima, S., Koike, T., Jin, Y., … Fan, J. (2006). Macrophage metalloelastase accelerates the progression of atherosclerosis in transgenic rabbits. Circulation, 113(16), 1993–2001. doi: 10.1161/circulationaha.105.596031
   PubMed Web of Science ®Google Scholar
• Liu, M., Sun, H., Wang, X., Koike, T., Mishima, H., Ikeda, K., … Fan, J. (2004). Association of increased expression of macrophage elastase (matrix metalloproteinase 12) with rheumatoid arthritis. Arthritis & Rheumatism, 50(10), 3112–3117. doi: 10.1002/art.20567
   PubMedGoogle Scholar
• Lixia, S., Hongbin, Y., Jie, L., Tianduanyi, W., Weihua, L., Guixia, L., & Yun, T. (2018). In silico prediction of compounds binding to human plasma proteins by QSAR models. ChemMedChem, 13(6), 572–581. doi: 10.1002/cmdc.201700582
   PubMed Web of Science ®Google Scholar
• Macalino, S. J. Y., Gosu, V., Hong, S., & Choi, S. (2015). Role of computer-aided drug design in modern drug discovery. Archives of Pharmacal Research, 38(9), 1686–1701. doi: 10.1007/s12272-015-0640-5
   PubMed Web of Science ®Google Scholar
• Maestro (Version 10.2.010). (2015). New York, NY, USA: Schrödinger, LLC.
   Google Scholar
• Mannino, C., Nievo, M., Machetti, F., Papakyriakou, A., Calderone, V., Fragai, M., & Guarna, A. (2006). Synthesis of bicyclic molecular scaffolds (BTAa): An investigation towards new selective MMP-12 inhibitors. Bioorganic & Medicinal Chemistry, 14(22), 7392–7403. doi: https://doi.org/10.1016/j.bmc.2006.07.028
   PubMed Web of Science ®Google Scholar
• Matsumoto, S.-I., Kobayashi, T., Katoh, M., Saito, S., Ikeda, Y., Kobori, M., … Watanabe, T. (1998). Expression and localization of matrix metalloproteinase-12 in the aorta of cholesterol-fed rabbits: Relationship to lesion development. The American Journal of Pathology, 153(1), 109–119. doi: https://doi.org/10.1016/S0002-9440(10)65551-4
   PubMed Web of Science ®Google Scholar
• Matthews, B. W. (1975). Comparison of the predicted and observed secondary structure of T4 phage lysozyme. Biochimica et Biophysica Acta (BBA) - Protein Structure, 405(2), 442–451. doi: https://doi.org/10.1016/0005-2795(75)90109-9
   PubMed Web of Science ®Google Scholar
• MOE (The Molecular Operating Environment) (Version 2009). (2009). Montreal, Quebec, Canada: Chemical Computing Group Inc.
   Google Scholar
• Molet, S., Belleguic, C., Lena, H., Germain, N., Bertrand, C. P., Shapiro, S. D., … Lagente, V. (2005). Increase in macrophage elastase (MMP-12) in lungs from patients with chronic obstructive pulmonary disease. Inflammation Research, 54(1), 31–36. doi: 10.1007/s00011-004-1319-4
   PubMed Web of Science ®Google Scholar
• Morales, R., Perrier, S., Florent, J.-M., Beltra, J., Dufour, S., De Mendez, I., … O'Gara, M. (2004). Crystal structures of novel non-peptidic, non-zinc chelating inhibitors bound to MMP-12. Journal of Molecular Biology, 341(4), 1063–1076. doi: https://doi.org/10.1016/j.jmb.2004.06.039
   PubMed Web of Science ®Google Scholar
• Nabha, S. M., dos Santos, E. B., Yamamoto, H. A., Belizi, A., Dong, Z., Meng, H., … Cher, M. L. (2008). Bone marrow stromal cells enhance prostate cancer cell invasion through type I collagen in an MMP-12 dependent manner. International Journal of Cancer, 122(11), 2482–2490. doi: 10.1002/ijc.23431
   PubMed Web of Science ®Google Scholar
• Nagase, H., Visse, R., & Murphy, G. (2006). Structure and function of matrix metalloproteinases and TIMPs. Cardiovascular Research, 69(3), 562–573. doi: 10.1016/j.cardiores.2005.12.002
   PubMed Web of Science ®Google Scholar
• Nar, H., Werle, K., Bauer, M. M. T., Dollinger, H., & Jung, B. (2001). Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor. Journal of Molecular Biology, 312(4), 743–751. doi: 10.1006/jmbi.2001.4953
   PubMed Web of Science ®Google Scholar
• Nordström, H., Gossas, T., Hämäläinen, M., Källblad, P., Nyström, S., Wallberg, H., & Danielson, U. H. (2008). Identification of MMP-12 inhibitors by using biosensor-based screening of a fragment library. Journal of Medicinal Chemistry, 51(12), 3449–3459. doi: 10.1021/jm8000289
   PubMed Web of Science ®Google Scholar
• Nuti, E., Cuffaro, D., D’Andrea, F., Rosalia, L., Tepshi, L., Fabbi, M., … Rossello, A. (2016). Sugar-based arylsulfonamide carboxylates as selective and water-soluble matrix metalloproteinase-12 inhibitors. ChemMedChem, 11(15), 1626–1637. doi: 10.1002/cmdc.201600235
   PubMed Web of Science ®Google Scholar
• Nuti, E., Panelli, L., Casalini, F., Avramova, S. I., Orlandini, E., Santamaria, S., … Rossello, A. (2009). Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 Inhibitors. Journal of Medicinal Chemistry, 52(20), 6347–6361. doi: 10.1021/jm900335a
   PubMed Web of Science ®Google Scholar
• Pirard, B. (2007). Insight into the structural determinants for selective inhibition of matrix metalloproteinases. Drug Discovery Today, 12(15), 640–646. doi: https://doi.org/10.1016/j.drudis.2007.06.003
   PubMed Web of Science ®Google Scholar
• Rodríguez-Pla, A., Martínez-Murillo, F., Savino, P. J., Eagle, J. R. C., Seo, P., & Soloski, M. J. (2009). MMP-12, a novel matrix metalloproteinase associated with giant cell arteritis. Rheumatology, 48(11), 1460–1461. doi: 10.1093/rheumatology/kep271
   PubMed Web of Science ®Google Scholar
• Rokach, L., & Maimon, O. (2005). Top-down induction of decision trees classifiers—A survey. IEEE Transactions on Systems, Man, and Cybernetics, Part C (Applications and Reviews), 35(4), 476–487. doi:10.1109/TSMCC.2004.843247
   Web of Science ®Google Scholar
• Sarkar, S., Nuttall, R. K., Liu, S., Edwards, D. R., & Yong, V. W. (2006). Tenascin-C stimulates glioma cell invasion through matrix metalloproteinase-12. Cancer Research, 66(24), 11771–11780. doi: 10.1158/0008-5472.Can-05-0470
   PubMed Web of Science ®Google Scholar
• Shamsara, J., & Shahir-Sadr, A. (2014). A predictive HQSAR model for a series of tricycle core containing MMP-12 inhibitors with dibenzofuran ring. International Journal of Medicinal Chemistry, 2014, 1–9
   Google Scholar
• Shapiro, S. D., Kobayashi, D. K., & Ley, T. J. (1993). Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. Journal of Biological Chemistry, 268(32), 23824–23829.
   PubMed Web of Science ®Google Scholar
• Singh, U., Gangwal, R. P., Prajapati, R., Dhoke, G. V., & Sangamwar, A. T. (2013). 3D QSAR pharmacophore-based virtual screening and molecular docking studies to identify novel matrix metalloproteinase 12 inhibitors. Molecular Simulation, 39(5), 385–396. doi: 10.1080/08927022.2012.731506
   Web of Science ®Google Scholar
• Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014). Computational methods in drug discovery. Pharmacological Reviews, 66(1), 334–395. doi: 10.1124/pr.112.007336
   PubMed Web of Science ®Google Scholar
• Terfloth, L., Spycher, S., & Gasteiger, J. (2018). Drug discovery: An overview. In E. Thomas & J. Gasteiger (Eds.), Applied chemoinformatics: Achievements and future opportunities. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA.
   Google Scholar
• Tetko, I. V., Gasteiger, J., Todeschini, R., Mauri, A., Livingstone, D., Ertl, P., … Prokopenko, V. V. (2005). Virtual computational chemistry laboratory—Design and description. Journal of Computer-Aided Molecular Design, 19(6), 453–463. doi: 10.1007/s10822-005-8694-y
   PubMed Web of Science ®Google Scholar
• Todeschini, R., & Consonni, V. (2008). Handbook of Molecular Descriptors (Vol. 11): Weinheim, Germany: John Wiley & Sons.
   Google Scholar
• Vaalamo, M., Kariniemi, A.-L., Saarialho-Kere, U., & Shapiro, S. D. (1999). Enhanced expression of human metalloelastase (MMP-12) in cutaneous granulomas and macrophage migration. Journal of Investigative Dermatology, 112(4), 499–505. doi: https://doi.org/10.1046/j.1523-1747.1999.00547.x
   PubMed Web of Science ®Google Scholar
• Vapnik, V. N. (2000). The vicinal risk minimization principle and the SVMs. In V. N. Vapnik (Ed.), The nature of statistical learning theory (pp. 267–290). New York, NY: Springer New York.
   Google Scholar
• Verma, R. P., & Hansch, C. (2007). Matrix metalloproteinases (MMPs): Chemical–biological functions and (Q)SARs. Bioorganic & Medicinal Chemistry, 15(6), 2223–2268. doi: https://doi.org/10.1016/j.bmc.2007.01.011
   PubMed Web of Science ®Google Scholar
• Vos, C. M. P., van Haastert, E. S., de Groot, C. J. A., van der Valk, P., & de Vries, H. E. (2003). Matrix metalloproteinase-12 is expressed in phagocytotic macrophages in active multiple sclerosis lesions. Journal of Neuroimmunology, 138(1), 106–114. doi: 10.1016/S0165-5728(03)00036-5
   PubMed Web of Science ®Google Scholar
• Wei, Y. C. (2011). PaDEL-descriptor: An open source software to calculate molecular descriptors and fingerprints. Journal of Computational Chemistry, 32(7), 1466–1474. doi: 10.1002/jcc.21707
   PubMed Web of Science ®Google Scholar
• Wells, J. E. A., Biernaskie, J., Szymanska, A., Larsen, P. H., Yong, V. W., & Corbett, D. (2005). Matrix metalloproteinase (MMP)-12 expression has a negative impact on sensorimotor function following intracerebral haemorrhage in mice. European Journal of Neuroscience, 21(1), 187–196. doi: 10.1111/j.1460-9568.2004.03829.x
   PubMed Web of Science ®Google Scholar
• Wells, J. E. A., Rice, T. K., Nuttall, R. K., Edwards, D. R., Zekki, H., Rivest, S., & Yong, V. W. (2003). An adverse role for matrix metalloproteinase 12 after spinal cord injury in mice. Journal of Neuroscience, 23(31), 10107–10115
   PubMed Web of Science ®Google Scholar
• Werb, Z., & Gordon, S. (1975). Elastase secretion by stimulated macrophages. Characterization and regulation. Journal of Experimental Medicine, 142(2), 361–377. doi: 10.1084/jem.142.2.361
   PubMed Web of Science ®Google Scholar
• Whittaker, M., Floyd, C. D., Brown, P., & Gearing, A. J. H. (1999). Design and therapeutic application of matrix metalloproteinase inhibitors. Chemical Reviews, 99(9), 2735–2776. doi: 10.1021/cr9804543
   PubMed Web of Science ®Google Scholar
• Willett, P., Barnard, J. M., & Downs, G. M. (1998). Chemical similarity searching. Journal of Chemical Information and Computer Sciences, 38(6), 983–996. doi: 10.1021/ci9800211
   Google Scholar
• Xue, Y., Yap, C. W., Sun, L. Z., Cao, Z. W., Wang, J. F., & Chen, Y. Z. (2004). Prediction of P-glycoprotein substrates by a support vector machine approach. Journal of Chemical Information and Computer Sciences, 44(4), 1497–1505. doi: 10.1021/ci049971e
   PubMedGoogle Scholar
• Yang, X. G., Lv, W., Chen, Y. Z., & Xue, Y. (2010). In silico prediction and screening of γ-secretase inhibitors by molecular descriptors and machine learning methods. Journal of Computational Chemistry, 31(6), 1249–1258. doi: 10.1002/jcc.21411
   Web of Science ®Google Scholar